Tirzepatide, which is sold under the brand name Mounjaro, has been approved for use by diabetes patients in the UK and its manufacturer hopes approval for weight loss treatment will follow
And it was 23 per cent more effective at bringing down blood sugar levels among people with diabetes, the study found.
“While individual trials have shown the efficacy of both semaglutide and tirzepatide versus placebo or other antidiabetic drugs, direct comparisons between these medications have been limited.” “Adding more weaponry to our arsenal is beneficial both to patients, who have increased choice about which drugs they can take, as well as health care systems with increased competition amongst manufacturers and the cost benefits that this brings.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
Tirzepatide more effective in blood sugar control and body weight loss than semaglutide, shows meta-analysisA new meta-analysis combining 22 studies, to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2–6 October), shows that tirzepatide is superior to semaglutide for both control of blood sugar and in terms of amount of body weight lost by patients. The study is by Dr. Thomas Karagiannis, Aristotle University of Thessaloniki, Thessaloniki, Greece, and colleagues.
Læs mere »